Related Experiment Video
Updated: Aug 8, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Multiple roles for the receptor tyrosine kinase axl in tumor formation
Sacha J Holland1, Mark J Powell, Christian Franci
1Rigel, Inc., South San Francisco, California and University of Michigan School of Dentistry, Ann Arbor, MI, USA. sholland@rigel.com
Abstract:
A focus of contemporary cancer therapeutic development is the targeting of both the transformed cell and the supporting cellular microenvironment. Cell migration is a fundamental cellular behavior required for the complex interplay between multiple cell types necessary for tumor development. We therefore developed a novel retroviral-based screening technology in primary human endothelial cells to discover genes that control cell migration. We identified the receptor tyrosine kinase Axl as a novel regulator of endothelial cell haptotactic migration towards the matrix factor vitronectin. Using small interfering RNA-mediated silencing and overexpression of wild-type or mutated receptor proteins, we show that Axl is a key regulator of multiple angiogenic behaviors including endothelial cell migration, proliferation, and tube formation in vitro. Moreover, using sustained, retrovirally delivered short hairpin RNA (shRNA) Axl knockdown, we show that Axl is necessary for in vivo angiogenesis in a mouse model. Furthermore, we show that Axl is also required for human breast carcinoma cells to form a tumor in vivo. These findings indicate that Axl regulates processes vital for both neovascularization and tumorigenesis. Disruption of Axl signaling using a small-molecule inhibitor will hence simultaneously affect both the tumor and stromal cell compartments and thus represents a unique approach for cancer therapeutic development.
Insights
The receptor tyrosine kinase Axl regulates endothelial cell migration and angiogenesis. Targeting Axl may offer a novel therapeutic strategy for cancer by impacting both tumor cells and their supportive microenvironment.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Cancer therapeutic development increasingly targets the tumor microenvironment.
- Cell migration is crucial for tumor development and involves complex cellular interactions.
- Identifying novel regulators of cell migration is key for new cancer therapies.
Purpose of the Study:
- To discover genes controlling endothelial cell migration using a novel retroviral screening technology.
- To investigate the role of the receptor tyrosine kinase Axl in cell migration and angiogenesis.
- To evaluate Axl's necessity in tumor formation and neovascularization.
Main Methods:
- Developed a retroviral-based screening technology in primary human endothelial cells.
- Utilized small interfering RNA (siRNA) for gene silencing and protein overexpression.
- Employed short hairpin RNA (shRNA) for sustained Axl knockdown in vivo.
- Assessed Axl's role in angiogenesis and tumor formation in mouse models.
Main Results:
- Identified Axl as a novel regulator of endothelial cell haptotactic migration towards vitronectin.
- Demonstrated that Axl controls endothelial cell migration, proliferation, and tube formation in vitro.
- Confirmed Axl's necessity for in vivo angiogenesis.
- Showed Axl is required for human breast carcinoma cell tumor formation in vivo.
Conclusions:
- Axl is a critical regulator of both angiogenesis and tumorigenesis.
- Targeting Axl signaling presents a unique therapeutic approach for cancer.
- Inhibiting Axl could simultaneously impact tumor and stromal cells, offering a dual-action strategy.
Related Concept Videos
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Mitogens and the Cell Cycle
The Ras Gene
Ras is a superfamily...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Receptor Tyrosine Kinases
MAPK Signaling Cascades

